AbbVie Deutschland GmbH & Co. KG
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PYLERA capsule, hard 140 mg+125 mg+125 mg
- A09 - Digestivos, incl. enzimas
- PANZYTRAT gastro-resistant capsule, hard 10 000 IU+9 000 IU+500 IU
- PANZYTRAT gastro-resistant capsule, hard 25 000 IU+12 000 IU+800 IU
- PANZYTRAT gastro-resistant capsule, hard 40 000 IU+15 000 IU+900 IU
- PANZYTRAT OK gastro-resistant granules 20 000 IU+18 000 IU+1 000 IU
- H05 - Homeostasis del calcio
- ZEMPLAR capsule, soft 1 µg
- ZEMPLAR capsule, soft 2 µg
- ZEMPLAR solution for injection 5 µg/1 ml
- J05 - Antivirales de uso sistémico
- KALETRA film-coated tablet 100 mg+25 mg
- KALETRA film-coated tablet 200 mg+50 mg
- KALETRA oral solution 80 mg/ml+20 mg/ml
- MAVIRET film-coated tablet 100 mg+40 mg
- NORVIR film-coated tablet 100 mg
- NORVIR powder for oral suspension 100 mg
- L01 - Antineoplásicos
- VENCLYXTO film-coated tablet 10 mg
- VENCLYXTO film-coated tablet 100 mg
- VENCLYXTO film-coated tablet 50 mg
- L04 - Inmunosupresores
- HUMIRA IM FERTIGPEN solution for injection 40 mg/0.4 ml
- HUMIRA IM FERTIGPEN solution for injection 80 mg/0.8 ml
- HUMIRA IN EINER FERTIGSPRITZE solution for injection 20 mg/0.2 ml
- HUMIRA IN EINER FERTIGSPRITZE solution for injection 40 mg/0.4 ml
- RINVOQ prolonged-release tablet 15 mg
- RINVOQ prolonged-release tablet 30 mg
- RINVOQ prolonged-release tablet 45 mg
- SKYRIZI IM FERTIGPEN solution for injection 150 mg/1 ml
- SKYRIZI IN EINER FERTIGSPRITZE solution for injection 150 mg/1 ml
- SKYRIZI IN EINER FERTIGSPRITZE solution for injection 75 mg/0.83 ml
- N01 - Anestésicos
- FORENE inhalation vapour, liquid 100%
- SEVORANE inhalation vapour, liquid 100%
- N04 - Antiparkinsonianos
- DUODOPA gel for injection 20 mg/ml+5 mg/ml
- S01 - Oftalmológicos
- LUMIGAN eye drops, solution 0.1 mg/ml
- LUMIGAN eye drops, solution 0.3 mg/ml
- LUMIGAN IM EINZELDOSISBEHÄLTNIS eye drops, solution 0.12 mg/0.4 ml
- OZURDEX implant 700 µg
- RELESTAT eye drops, solution 0.5 mg/ml